A working paradigm for the treatment of obesity in gastrointestinal practice
Obesity is a chronic, relapsing, multifactorial disease characterized by abnormal or excessive adipose tissue accumulation that may impair health and increase disease risks. Despite the ever-increasing prevalence and economic and societal burden, the current approaches to treat obesity are not standardized or generally effective. In this article, we describe a current working paradigm developed by a consensus approach for the multidisciplinary treatment of obesity in the gastrointestinal practice. (Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - January 24, 2017 Category: Gastroenterology Authors: Andres Acosta, Michael Camilleri Source Type: research

A Working Paradigm for the Treatment of Obesity in GI Practice
Obesity is a chronic, relapsing, multi-factorial disease characterized by abnormal or excessive adipose tissue accumulation that may impair health and increase disease risks. Despite the ever-increasing prevalence and economic and societal burden, the current approaches to treat obesity are not standardized or generally effective. In this manuscript, we describe a current working paradigm developed by a consensus approach for the multidisciplinary treatment of obesity in the GI practice. Obesity should be managed as a continuum of care focusing on weight loss, weight loss maintenance and prevention of weight regain. (Sourc...
Source: Techniques in Gastrointestinal Endoscopy - January 24, 2017 Category: Gastroenterology Authors: Andres Acosta, Michael Camilleri Source Type: research

Preface
The global epidemic of obesity, when evaluated in the context of the insidious role it plays in the health and well being of the population, is undoubtedly the paramount health care issue that we face. Through the lense of gastroenterology alone, obesity is a significant risk factor for GERD, Barrett ′s, Gallbladder Disease, Pancreatitis, NAFLD, Cirrhosis, Colon Adenomas and Adenocarcinomas of the esophagus, stomach, pancreas, liver, and colon. The complexity of obesity has only recently been appreciated, and there have been fascinating developments in understanding the interplay of genetic, e pigenetic, physiologic and ...
Source: Techniques in Gastrointestinal Endoscopy - January 16, 2017 Category: Gastroenterology Authors: Sarah E. Streett Tags: SI: Endoscopic Bariatric Procedures: Considerations and Expe Source Type: research

Gastric space –occupying devices
Despite advances in lifestyle interventions, antiobesity medications and metabolic surgery, obesity ׳s health burden continues to rise. Endoscopic bariatric techniques (EBTs) have arisen over the years that are efficacious, reversible, safe, and cost effective. These techniques potentially allow us to treat broader populations that are unable to undergo bariatric surgery. Gastric space–occupyin g devices are some of the most widely endoscopic metabolic therapies available. This review would summarize the gastric-occupying devices that are available in the US market or in advanced stages of development and regulatory app...
Source: Techniques in Gastrointestinal Endoscopy - January 13, 2017 Category: Gastroenterology Authors: Eric J. Vargas, Barham K. Abu Dayyeh Source Type: research

Gastric space-occupying devices
Despite advances in lifestyle interventions, anti-obesity medications and metabolic surgery, obesity ′s health burden continues to rise. Endoscopic bariatric techniques (EBTs) have arisen over the years that are efficacious, reversible, safe, and cost-effective. These techniques potentially allow us to treat broader populations that are unable to undergo bariatric surgery. Gastric space occupying devices are some of the most widely endoscopic metabolic therapies available. This review will summarize the gastric occupying devices that are available in the US market or in advanced stages of development and regulatory appro...
Source: Techniques in Gastrointestinal Endoscopy - January 13, 2017 Category: Gastroenterology Authors: Eric J. Vargas, Barham K. Abu Dayyeh Source Type: research

Masthead
(Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - January 1, 2017 Category: Gastroenterology Source Type: research

Editorial Board
(Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - January 1, 2017 Category: Gastroenterology Source Type: research

Table of Contents
(Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - January 1, 2017 Category: Gastroenterology Source Type: research

When to stop, how to reverse, and when to restart antithrombotic drugs periendoscopically in nonvariceal upper gastrointestinal bleeding
Upper gastrointestinal (GI) (UGI) bleeding in patients taking antithrombotics including antiplatelet agents, vitamin K antagonists, and direct oral anticoagulants is challenging because of varying clinical presentations that include the severity of hemorrhage, the type and magnitude of anticoagulation, the patient ׳s underlying thromboembolic risk, and the specific bleeding lesion with attendant ability to achieve successful endoscopic hemostasis. Interruption of antithrombotics for bleeding management exposes the patient to the underlying risk of thromboembolic events from the underlying cardiovascular stat e, whereas co...
Source: Techniques in Gastrointestinal Endoscopy - December 21, 2016 Category: Gastroenterology Authors: David R. Lichtenstein Source Type: research

When To Stop, How To Reverse And When To Restart Anti-Thrombotic Drugs Peri-Endoscopically in Non-Variceal Upper GI Bleeding
Upper GI (UGI) bleeding in patients taking antithrombotics including antiplatelet agents, vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) is challenging because of varying clinical presentations that include the severity of hemorrhage, the type and magnitude of anticoagulation, the patient ′s underlying thromboembolic risk and the specific bleeding lesion with attendant ability to achieve successful endoscopic hemostasis. Interruption of antithrombotics for bleeding management exposes the patient to the underlying risk of thromboembolic events from the underlying cardiovascular (CV) state while contin...
Source: Techniques in Gastrointestinal Endoscopy - December 21, 2016 Category: Gastroenterology Authors: David R. Lichtenstein Tags: SI: Endoscopic Management of Nonvariceal Upper GI Bleeding Source Type: research

Mechanical methods to endoscopically treat nonvariceal upper gastrointestinal bleeding
Acute upper gastrointestinal bleeding (UGIB) is a frequent condition worldwide. The most common causes of acute nonvariceal UGIB include ulcers and nonulcer etiology, such as mucosal erosive disease, Mallory-Weiss tear, Dieulafoy, and other vascular lesions. Today patients are older and more likely to have comorbidities and concomitant treatments: anticoagulants, antiplatelet agent, low dose aspirin or steroidal anti-inflammatory drugs. In these patients with UGIB the rebleeding risk, need for surgery, and mortality rates are higher. (Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - December 8, 2016 Category: Gastroenterology Authors: Livio Cipolletta, Fabio Cipolletta, Clelia Marmo, Roberto Piscopo, Gianluca Rotondano, Riccardo Marmo Source Type: research

Risk stratification and definitive hemostasis of nonvariceal upper gastrointestinal bleeding with blood flow detection and combination techniques
Nonvariceal upper gastrointestinal (UGI) hemorrhage remains a significant health and economic burden. As the use of urgent endoscopy for UGI hemorrhage has increased, there has been a decline in associated mortality. Endoscopic hemostasis is based on risk stratification of stigmata of recent hemorrhage. A Doppler endoscopic probe can provide further risk stratification by detecting arterial blood flow under the lesion and as a guide to successful endoscopic treatment. Standard treatment options for endoscopic hemostasis include submucosal injection therapy usually in combination with either thermal coagulation or through-t...
Source: Techniques in Gastrointestinal Endoscopy - December 8, 2016 Category: Gastroenterology Authors: Kevin A. Ghassemi, Dennis M. Jensen Source Type: research

Nonvariceal upper gastrointestinal bleeding refractory to endoscopy: The role of interventional radiology and surgery
Acute nonvariceal upper gastrointestinal bleeding is a common and life-threatening emergency. Despite optimal endoscopic and pharmacologic therapy, 8%-10% of patients continue to bleed or develop rebleeding. Surgery has been the traditional salvage treatment in these patients. However, surgery is associated with high morbidity and mortality rates. In the past few decades, transarterial embolization has emerged as a promising nonoperative alternative to surgery. High technical (69%-100%) and clinical success rate (63%-97%) were reported. (Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - December 8, 2016 Category: Gastroenterology Authors: Shannon Melissa Chan, James Yun Wong Lau Source Type: research

Hemostatic sprays to control active nonvariceal upper gastrointestinal bleeding
As nonvariceal upper gastrointestinal bleeding remains a critical health concern, there is a need for ongoing optimization of endoscopic hemostasis modalities. Current methods for endoscopic hemostasis include epinephrine injection, thermal coagulation, and mechanical clips. Although these modalities have proven efficacy, there are limitations to their use, including significant learning curves and the requirement of expert assistants. Moreover, there still remains an ongoing risk of rebleeding after therapy. (Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - December 8, 2016 Category: Gastroenterology Authors: Neal Shahidi, Robert Enns Source Type: research

Argon plasma coagulation and radiofrequency ablation in nonvariceal upper gastrointestinal bleeding
Upper gastrointestinal bleeding (UGIB) is one of the most common causes of emergency department visits worldwide and represents a significant public health problem in many countries. Endoscopy plays a major role in the diagnosis and treatment of UGIB. Endoscopic hemostasis of peptic ulcer bleeding is preferably achieved by the combination of injection with contact thermal methods or mechanical methods. Argon plasma coagulation (APC) is a noncontact thermal method of hemostasis that has been employed to treat bleeding angioectasia. (Source: Techniques in Gastrointestinal Endoscopy)
Source: Techniques in Gastrointestinal Endoscopy - December 8, 2016 Category: Gastroenterology Authors: Ernesto Quaresma Mendonca, Joel Fernandez de Oliveira, Fauze Maluf-Filho Source Type: research